image: Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. This material relates to a paper that appeared in the 16 May, issue of Science Translational Medicine, published by AAAS. The paper, by T.L. Lochmann at Virginia Commonwealth University Philips Institute in Richmond, VA; and colleagues was titled, "Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma." view more
Credit: Ynes Bouck, www.ynesbouck.com